Seeking men and women with Amyotrophic Lateral Sclerosis (ALS) to participate in a research trial to test several different investigational treatments.
We are comparing a series of different investigational drug regimens to placebo (looks like the drug but contains no active medicine). Participants have at 75% chance of receiving one of the investigational drug regimens and a 25% chance of receiving the placebo.
What we're hoping for
We hope that the investigational treatments will slow the progression of Amyotrophic Lateral Sclerosis (ALS) or improve ALS symptoms.
ClinicalTrials.gov Identifier: NCT04297683